The FDA has proposed cutting fees for early-stage companies conducting clinical development in the U.S. instead of abroad. | ...

Hugo is heading to the U.S., with Medtronic finally securing a stateside clearance for its robotic surgery platform. | The ...

A new CRO called Avetra has emerged with a mission of modernizing clinical research operations by prioritizing transparency ...

Triana Biomedicines has tapped Pfizer Ventures and a number of other existing and new investors to secure a $120 million ...

The FDA has approved a novel diagnostic for prostate cancer that looks to improve upon the common screener for ...

In 105 boys and young men enrolled in the HOPE-3 trial, patients given deramiocel every three months for a year had 54% ...

Laboratoires Théa has penned a deal potentially worth up to $280 million to get its hands on Iolyx Therapeutics’ phase ...

Investigators randomized 134 people with hereditary angioedema (HAE) to receive deucrictibant or placebo. Participants took ...

Swan EndoSurgical, a gastrointestinal startup launched by Olympus and Revival Healthcare Capital earlier this year, has named ...

Muvon Therapeutics has linked its cell therapy to a 60% drop in stress incontinence episode frequency in a small phase 2 ...